Navigation Links
EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
Date:5/15/2009

er expanded its clinical development efforts for ENMD-2076 and has commenced a Phase 1 study in patients with relapsed or refractory leukemia. The study will be conducted at the Princess Margaret Hospital in Toronto, Ontario and Karen Yee, M.D., will serve as Principal Investigator. Although the primary endpoints of the study include defining the maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of ENMD-2076 administered orally in patients with relapsed or refractory leukemia, the study will also evaluate pharmacodynamic effects of ENMD-2076 by collaborating with Dr. David Hedley, Department of Molecular Oncology, Ontario Cancer Institute (OCI).

Dr. Mark R. Bray, EntreMed Vice President, Research commented, "We are very excited to be working with Dr. Hedley and his staff, who have considerable experience in evaluating the mechanistic effects of kinase inhibitors like ENMD-2076 in cancer patients. The close proximity of EntreMed scientific personnel based in Toronto to our clinical collaborators at the OCI will facilitate our ability to obtain the maximum value from this study and its correlative components."

In addition, the U.S. Food and Drug Administration (FDA) granted orphan drug designation for ENMD-2076 for the treatment of ovarian cancer. Several ovarian cancer patients participated in the ENMD-2076 Phase 1 study in solid tumors and will be included in the data presentations at ASCO. Orphan drug is a designation by the Food and Drug Administration indicating a therapy developed to treat diseases that affect fewer than 200,000 persons in the United States. Sponsors of drugs granted orphan designation qualify for tax credit and marketing exclusivity incentives of the Orphan Drug Act. Previously EntreMed had received orphan drug designation for ENMD-2076 for multiple myeloma.

EntreMed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., commented, "The clinical development
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
2. EntreMed to Present at the New York Society of Security Analysts Industry Conference
3. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
4. EntreMed Reports Third Quarter 2008 Financial Results
5. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
6. EntreMed to Present at BioPartnering Europe Conference
7. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
8. EntreMed Reports Second Quarter 2008 Financial Results
9. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
10. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... remarkable rate of development in the information technology industry ... in the field. Staying astride the flow of technological ... and students alike. , ,That is why IT experts ... mutual assistance, especially when the goal is educating the ...
... New thin-film semiconductor techniques invented by University of ... imaging capability to an amazing array of materials. ... two-dimensional chips upon which to grow and etch the ... computers and other electronic devices. But as thin as ...
... NimbleGen Systems, Inc. , a producer of high-density microarrays, ... used for studying DNA interactions inside the cell. , ... opening the door for organizations like Yale University ... UC-San Diego to work with NimbleGen's chromatin immunoprecipitation ...
Cached Biology Technology:MATC boot camp keeps IT instructors up to date 2MATC boot camp keeps IT instructors up to date 3MATC boot camp keeps IT instructors up to date 4MATC boot camp keeps IT instructors up to date 5UW produces fast and flexible computer chip 2NimbleGen partners with leading researchers 2
(Date:4/14/2014)... scientists are continuing to unravel the molecular changes that ... respiratory infections. , When the bacterium Yersinia pestis enters ... is 100 percent fatal if untreated. The way in ... and kills people in a matter of days has ... study demonstrating that the presence of a protein called ...
(Date:4/14/2014)... WEST LAFAYETTE, Ind. - High levels of the greenhouse ... a production point not thought to be an important ... Purdue and Cornell universities. The findings could have implications ... gas production. , The study, which is one of ... approach that measures methane gas levels in the air ...
(Date:4/14/2014)... Kisailus, the Winston Chung Endowed Chair of Energy ... College of Engineering, has been named a Kavli ... by the advisory board of the Kavli Foundation, ... organizers of the Kavli/National Academy of Sciences Frontiers ... is based in Oxnard, supports scientific research, honors ...
Breaking Biology News(10 mins):Plague alters cell death to kill host 2'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2Professor receives young scientist honor 2
... of the words "parasitic worms," it's a fact that some ... Michigan State University, researcher Linda Mansfield is part of a ... play in treating inflammatory bowel disease, or IBD, in humans. ... million National Institutes of Health grant supporting the Food and ...
... into the closest freshwater pond, you'd hesitate before dipping ... an oddly furry, pear-shaped organism gliding along--and gobbling up ... has a big name-- Tetrahymena thermophila --and a big ... research into how cells work. , Scientists have now ...
... improved technique for culturing cells, developed at the National ... fundamental insights into the behavior of neuronal cells. , ... basic technique for measuring how they respond to various ... Neuronal cells, which make up the central nervous system ...
Cached Biology News:Parasitic worms used to fight bowel disease 2What's shaped like a pear and has 2 genomes? Check the pond 2What's shaped like a pear and has 2 genomes? Check the pond 3Neuronal cell cultures kept on the straight and narrow 2
... strains are K-12 derivatives that have mutations ... glutathione reductase (gor) genes, which greatly enhances ... have shown that expression in Origami(DE3) yielded ... host even though overall expression levels were ...
Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
... Cy3 Ab Labeling Kit, 1 kit. ... CyDye fluorescent dyes. Conjugations are carried ... within 1 h. Dyes are packaged ... ensure consistent labelings. Category: Blotting & ...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Biology Products: